# Project Log

This document records the key steps, decisions, and iterations in the development of the project pipeline.

---

## 2026-01-21 - Initial Project Analysis
*   **Action:** Performed initial directory analysis and read `guidelines.md`.
*   **Outcome:** Generated `GEMINI.md` to provide context for the project, identifying it as a non-code project focused on a corporate pipeline for generator phase brush swelling.

## 2026-01-21 - Department Identification
*   **Action:** Identified key departments within a hypothetical company relevant to the pipeline development.
*   **Outcome:** Created `departments.md` listing R&D, Product Management, Operations, QA, Supply Chain, and Maintenance.

## 2026-01-21 - Pipeline Version 0.0 (Provisional)
*   **Action:** Drafted the first provisional version of the pipeline.
*   **Outcome:** Created `pipeline_0.md` outlining a six-phase engineering-focused approach to the problem.

## 2026-01-21 - Critique of Pipeline V0.0 (Investor/Expert)
*   **Action:** Generated a critique from the perspective of an expert and investor.
*   **Outcome:** Created `critic_of_pipeline0.md`, highlighting gaps in vendor leverage, immediate containment strategies, financial impact analysis, and risk in validation.

## 2026-01-21 - Pipeline Version 1.0 (Strategic Flow)
*   **Action:** Revised `pipeline_0.md` based on the Investor/Expert critique.
*   **Outcome:** Created `pipeline_1.md`, incorporating immediate containment, vendor engagement, and financial gateways.

## 2026-01-21 - CEO Directive & Critique of Pipeline V1.0
*   **Action:** Generated a critique from the CEO's perspective with a strong strategic pivot.
*   **Outcome:** Created `critic_of_pipeline1.md`, rejecting the maintenance-focused pipeline and directing a shift towards proprietary material upgrade and commercialization.

## 2026-01-21 - Pipeline Version 2.0 (Product Innovation & Commercialization)
*   **Action:** Revised `pipeline_1.0` in direct response to the CEO's directive.
*   **Outcome:** Created `pipeline_2.md`, structured as a product development lifecycle focused on material science innovation and market launch.

## 2026-01-21 - CTO Technical Review & Critique of Pipeline V2.0
*   **Action:** Generated a critique from the CTO's perspective, focusing on technical feasibility and risks.
*   **Outcome:** Created `critic_of_pipeline2.md`, highlighting tribological risks, electrical conductivity concerns, mechanical strength issues, and the need for dynamic testing.

## 2026-01-21 - Pipeline Version 2.1 (Technical Safety & High-Performance Validation)
*   **Action:** Revised `pipeline_2.0` based on the CTO's technical critique.
*   **Outcome:** Created `pipeline2v1.md`, incorporating rigorous dynamic testing, tribological safety considerations, and the elimination of high-risk development tracks.

## 2026-01-21 - Pipeline Version 3.0 (Corporate Integration & Feasibility)
*   **Action:** Created a new pipeline iteration integrating specific insights from the team's `colegas.md`.
*   **Outcome:** Created `pipeline3.md`. This version balances the aggressive R&D of V2.0 with a "Feasibility Filter" (Finance/Product Mgmt) to assess costs (Ag content) and manufacturability early. It specifically incorporates the team's suggested technical tracks: Hydrophobic Additives, Alloy Modification, and Pre-conditioning.

## 2026-01-21 - Pipeline Version 3.0 (Spanish Translation)
*   **Action:** Translated `pipeline3.md` into Spanish.
*   **Outcome:** Created `pipeline3_esp.md`.

## 2026-01-22 - Project Constraints Update
*   **Action:** Updated `guidelines.md` and `GEMINI.md` to reflect new constraints provided by the user.
*   **Outcome:** The pipeline must now focus exclusively on R&D (I+D) activities and assume unlimited funding.

## 2026-01-22 - File Deletion
*   **Action:** Deleted `departments.md` as per user instruction.
*   **Outcome:** The project no longer explicitly lists departments, aligning with the R&D focus constraint.

## 2026-01-22 - Integration of Team Notes and Manufacturing Details
*   **Action:** Analyzed `brian.md`, `colegas_2.md`, and `pipeline_colegas.md`.
*   **Outcome:** Updated `GEMINI.md` to document the specific material (MG1157), the detailed manufacturing stages (mixing to finishing), and the team's proposed "4D Matrix" experimental strategy (identifying 4 parameters, narrowing to 2 critical ones).

## 2026-01-22 - Pipeline Version 4.0 (Collaborative R&D Strategy)
*   **Action:** Created a new pipeline version prioritizing the team's methodology (`pipeline_colegas.md`).
*   **Outcome:** Created `pipeline_4.md`, which strictly implements the 6-step workflow (4 Parameters -> OFAT Screening -> Statistical Analysis -> 2-Variable Optimization -> Decision) while maintaining the corporate R&D context.

## 2026-01-22 - CTO Critique of Pipeline V4.0
*   **Action:** Generated a critique from the CTO's perspective, demanding more technical detail.
*   **Outcome:** Created `critic_of_pipeline4.md`, highlighting the lack of specific protocols for ranges, OFAT decoupling, sample sizes, swelling measurement standards, and dynamic testing under load.

## 2026-01-22 - Pipeline Version 5.0 (High-Precision R&D)
*   **Action:** Created the definitive execution pipeline in response to the CTO's critique.
*   **Outcome:** Created `pipeline_5.md`. This version defines specific chemical candidates (Pitch, Furan, Silanes), precise numerical ranges (30-70% Ag), a decoupling strategy using pore-formers (PEG), Central Composite Design (CCD) for DoE, and rigorous dynamic validation protocols (20 A/cm² overload test).

## 2026-01-22 - CEO Directive on Material Scope & Visuals
*   **Action:** Generated a directive from the CEO questioning whether the tests involve only new ratios, only new materials, or both.
*   **Outcome:** Created `CEO_to_Head.md`. Demanded explicit clarity on the "New Materials vs. New Ratios" strategy and mandated the creation of 3D Surface Plots (X, Y, Swelling-Z) as the final project output, with separate plots for different material classes if necessary.

## 2026-01-22 - Head of Pipeline Response to CEO
*   **Action:** Drafted the response to the CEO's directive.
*   **Outcome:** Created `answer_to_CEO.md`. Confirmed "Option 3" (Full Matrix: New Materials AND New Ratios) and advocated for an additional "Carbon Phase" variable (Natural vs. Synthetic Graphite). Confirmed the delivery of Comparative 3D Surface Plots.

## 2026-01-22 - Corporate Identity Pivot
*   **Action:** Rebranded the project context from a hypothetical scenario to **Morgan Advanced Materials**.
*   **Outcome:** Updated `GEMINI.md` to reflect that we are the original manufacturers (Morgan) improving our own Grade MG1157 for wind turbine applications.

## 2026-01-22 - CEO Final Approval
*   **Action:** CEO (Morgan Advanced Materials) verified the "Carbon Phase" proposal against internal knowledge (Synthetic vs. Natural Graphite porosity) and approved the project.
*   **Outcome:** Created `CEO_Approval_and_Mandates.md`. Greenlit the "Full Matrix" approach with a critical mandate to monitor the "Tribological Safe Zone" to prevent dry-running failure.

## 2026-01-22 - Pipeline Version 6.0 (Final Approved Protocol)
*   **Action:** Created the final approved pipeline incorporating all CEO mandates.
*   **Outcome:** Created `pipeline_6.md`. This version executes the "Full Matrix" (Binders, Carbon Source, Metal Ratio, Porosity), integrates the Synthetic Graphite investigation, and establishes the "Tribological Safe Zone" ($\mu < 0.25$) as a critical failure criterion in the final 3D visualization deliverables.

## 2026-01-22 - CTO Technical Critique of Pipeline V6.0 (Patent Benchmark)
*   **Action:** Generated a critique from the CTO utilizing Patent EP 1780876 A1 as a benchmark.
*   **Outcome:** Created `critic_of_pipeline6.md`. Identified major gaps: lack of Solid Lubricants (MoS2/WS2) to compensate for hydrophobicity, insufficient test duration (168h vs 2000h), failure to measure Anisotropic Swelling, and rigid hardness targets.

## 2026-01-22 - Pipeline Version 7.0 (The "Morgan-Totankako" Benchmark Protocol)
*   **Action:** Created the final execution pipeline addressing all technical gaps.
*   **Outcome:** Created `pipeline_7.md`. This version adds **MoS2 (Solid Lubricant)** as a 5th variable, mandates **Anisotropic Swelling ($Z_{perpendicular}$)** measurements, implements **Accelerated Hydrothermal Aging** (120°C Autoclave) to simulate long-term saturation, and removes artificial hardness constraints.

## 2026-01-22 - CEO Strategic Review of Pipeline V7.0
*   **Action:** Generated a strategic review from the CEO asking to simplify the input parameters.
*   **Outcome:** Created `CEO_to_CTO.md`. Proposed narrowing the scope to 4 "Process Levers" (Binder, Pressing Pressure, Carbonization Temp, Coating) and excluding Metal Content and Solid Lubricants to streamline manufacturing, asking the CTO for validation.

## 2026-01-22 - CTO Technical Validation of Simplification
*   **Action:** Generated the technical validation of the CEO's simplified parameters.
*   **Outcome:** Created `CTO_2_CEO.md`. Confirmed that focusing on Binder, Pressure, Temperature, and Impregnation is scientifically sound and production-friendly. Addressed the lubrication risk by proposing "Lubricating Oils" in the impregnation step instead of dry MoS2 powder.

## 2026-01-22 - Pipeline Version 8.0 (Final "Process" Protocol)
*   **Action:** Created the streamlined execution plan based on the 4 Process Levers.
*   **Outcome:** Created `pipeline_8.md`. Focuses on Binder, Pressure, Temperature, and Impregnation. Created `left_behind_7_to_8.md` to document the exclusion of Metal Content, Solid Lubricants, and Synthetic Graphite investigation for future reference.

## 2026-01-22 - CTO Critique of Pipeline V8.0 (Operational Detail)
*   **Action:** Generated a critique from the CTO demanding detailed protocols.
*   **Outcome:** Created `critic_of_pipeline_8.md`. The CTO requires `pipeline_9.md` to include specific appendices for Binder Rheology, Pressing Cycles (decompression rates), Thermal Profiles (atmosphere control), and VPI cycles, rejecting vague instructions.

## 2026-01-22 - Pipeline Version 9.0 (Operational Master Plan)
*   **Action:** Created the final operational master document with 4 detailed appendices.
*   **Outcome:** Created `pipeline_9.md` and Appendices A-D.

## 2026-01-22 - Alignment with Colleague Methodology (Priority 1)
*   **Action:** Integrated the content of `colegas_3.md` as the guiding strategic document.
*   **Outcome:** Updated `GEMINI.md` to establish `colegas_3.md` as TOP PRIORITY, explicitly adopting the 4-Phase DOE methodology and the use of Jupyter/Python for statistical analysis.

## 2026-01-22 - Final Presentation Structure Alignment
*   **Action:** Synchronized all project guidelines and context files with the presentation structure (`pptx_structure.md`).
*   **Outcome:** Updated `guidelines.md` and `GEMINI.md` to mandate the specific narrative flow: Problem -> Theory -> Experiment -> Analysis, ensuring the entire project is "Presentation Ready".

## 2026-01-22 - Pipeline Version 10.0 (The Final Presentation Model)
*   **Action:** Created the definitive "Presentation Ready" pipeline integrating all stakeholders (Morgan R&D + Colleagues Team).
*   **Outcome:** Created `pipeline_10.md` and Appendices A-E.

## 2026-01-22 - Pipeline Version 11.0 (The Presentation Master)
*   **Action:** Created the definitive pipeline version optimized for 1:1 mapping with the final presentation slides.
*   **Outcome:** Created `pipeline_11.md` and Appendices A-E.

## 2026-01-22 - Slide Scripts Generation
*   **Action:** Generated 17 individual Markdown scripts for each slide of the final presentation based on `pptx_structure.md`.
*   **Outcome:** Created `script_for_diapositiva_1.md` through `script_for_diapositiva_17.md`, each containing a detailed prompt for HTML generation.

## 2026-01-29 - Project Directory Reorganization
*   **Action:** Restructured the project directory to improve organization and navigability.
*   **Outcome:** Created `communications/`, `pipelines/`, `critiques/`, and `technical_context/` folders. Moved relevant loose Markdown files into these specific categories to declutter the root directory.

## 2026-01-29 - Streamlit Application Development & GitHub Deployment
*   **Action:** Developed a Streamlit application to serve as an interactive viewer for the presentation slides (`htmls/`).
*   **Outcome:** Created `proyecto_streamlit/` containing `app.py` and the slides. Implemented advanced CSS patches to ensure responsiveness and fix clipping issues for both 4:3 and 16:9 slide formats. Deployed the full "end-to-end" repository to GitHub.
